Twist Bioscience Opens New Twist Boston Location
SOUTH SAN FRANCISCO, Calif. – July 6, 2022 – Twist Bioscience Corporation (NASDAQ: TWST), a...
The DiversimAb platform is a proprietary hyperimmune, autoimmune mouse platform, engineered for increased epitopic coverage. This allows us to make antibodies to epitopes, and targets on those epitopes, that other mouse models can not. Fill out the info below to download our poster that provides more info on the DiversimAb mouse.
Reach out to one of our scientists if you have any questions, enjoy!
SOUTH SAN FRANCISCO, Calif. – July 6, 2022 – Twist Bioscience Corporation (NASDAQ: TWST), a...